Fecal Microbiota Transplantation Shows No Benefit for Gastrointestinal Symptoms in Systemic Sclerosis
Fecal microbiota transplantation with an anaerobic cultivated human intestinal microbiome failed to improve gastrointestinal symptoms in patients with systemic sclerosis, a phase 2 study showed.